CapIQ
Source: S&P Capital IQ consensus via Xpressfeed · Generated 2026-07-22.
Normalized EPS estimates up ~7% for FY2027 in 90 days while revenue sits flat
The FY2027 EPS revision landed within the last three months; the 30-day change is negligible, so the re-rating has paused for now. Revenue estimates for both years have barely moved.
Currency: USD · Scale: money in millions, absolute · Point-in-time consensus; Δ90d is Now versus 90d.
| Metric | FY | 180d | 90d | 30d | Now | Δ90d |
|---|---|---|---|---|---|---|
| EPS (normalized) | FY2027 | $13.20 | $13.20 | $14.13 | $14.13 | +7.1% |
| EPS (normalized) | FY2028 | $15.14 | $14.93 | $15.50 | $15.51 | +3.9% |
| Revenue | FY2027 | $46.15bn | $46.14bn | $46.10bn | $46.11bn | -0.1% |
| Revenue | FY2028 | $50.61bn | $50.57bn | $50.55bn | $50.51bn | -0.1% |
Normalized-EPS beats are accelerating - 14%, 25%, 24% - while revenue lands on the number
Current sequences by metric: Revenue: 2 consecutive beats; EPS (normalized): 6 consecutive beats.
Currency: USD · Scale: money in millions, absolute · Consensus is captured before each actual first became effective.
| Quarter | Metric | Consensus | Actual | Surprise | Outcome |
|---|---|---|---|---|---|
| Q1 FY2027 | Revenue | $11.06bn | $11.13bn | +0.7% | Beat |
| Q1 FY2027 | EPS (normalized) | $3.13 | $3.88 | +24.1% | Beat |
| Q4 FY2026 | Revenue | $11.19bn | $11.20bn | +0.1% | Beat |
| Q4 FY2026 | EPS (normalized) | $3.05 | $3.81 | +24.9% | Beat |
| Q3 FY2026 | Revenue | $10.27bn | $10.26bn | -0.1% | Miss |
| Q3 FY2026 | EPS (normalized) | $2.86 | $3.25 | +13.6% | Beat |
| Q2 FY2026 | Revenue | $10.14bn | $10.24bn | +1.0% | Beat |
| Q2 FY2026 | EPS (normalized) | $2.78 | $2.91 | +4.7% | Beat |
| Q1 FY2026 | Revenue | $9.75bn | $9.83bn | +0.8% | Beat |
| Q1 FY2026 | EPS (normalized) | $2.55 | $2.58 | +1.3% | Beat |
| Q4 FY2025 | Revenue | $10.04bn | $9.99bn | -0.4% | Miss |
| Q4 FY2025 | EPS (normalized) | $2.61 | $2.78 | +6.4% | Beat |
| Q3 FY2025 | Revenue | $9.35bn | $9.44bn | +1.0% | Beat |
| Q3 FY2025 | EPS (normalized) | $2.45 | $2.41 | -1.5% | Miss |
| Q2 FY2025 | Revenue | $9.23bn | $9.32bn | +1.0% | Beat |
| Q2 FY2025 | EPS (normalized) | $2.36 | $2.56 | +8.7% | Beat |
Consensus models ~10% revenue growth through FY2029 with EPS compounding faster
Currency: USD · Scale: money in millions, absolute · YoY uses the prior fiscal year from the feed; analyst count and range use the first displayed period.
| Metric | FY2026A | FY2027E | FY2028E | FY2029E | YoY | Analysts | Low / high |
|---|---|---|---|---|---|---|---|
| Revenue | $41.50bn | $46.11bn | $50.51bn | $55.28bn | +9.5% | 44 | $41.19bn / $41.62bn |
| EPS (normalized) | $11.77 | $14.13 | $15.51 | $17.95 | +15.4% | 44 | $11.50 / $11.92 |
Analysts split on the outer-year margin path: FY2028 EPS spans $14.25-$17.47
On 53 estimates the FY2028 normalized-EPS range runs $14.25-$17.47 around a $15.51 mean; by FY2029 it widens to $15.65-$19.27 on just 22 estimates, so the dispersion is as much about coverage thinning as conviction.
Currency: USD · Scale: money in millions, absolute · Spread/mean is absolute high-low divided by absolute mean.
| Metric | Period | Mean | Low–high | Spread/mean | Analysts |
|---|---|---|---|---|---|
| EPS (normalized) | FY2028E | $15.51 | $14.25–$17.47 | 20.8% | 53 |
| EPS (normalized) | FY2029E | $17.95 | $15.65–$19.27 | 20.2% | 22 |
Street snapshot
Currency: USD · Scale: money in millions, absolute · Analyst counts shown explicitly.
| Street view | Reading | Analysts |
|---|---|---|
| Recommendation mix | Buy 34, Outperform 5, Hold 12, Underperform 2, Sell 0 | 53 |
| Consensus score | 1.66 | 53 |
| Target price | mean $241.7; median $236.0; high $475.0; low $160.0 | 53 |